Guidelines for the Use of Radio-iodine, Thyroid Hormone, and Treatment of Metastatic Disease in Patients With Differentiated Thyroid Cancer

Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma

1997 • 470 citations

Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients.

1992 • 351 citations

Quality-of-Life Changes in Patients with Thyroid Cancer After Withdrawal of Thyroid Hormone Therapy

1997 • 291 citations

Prognosis and Treatment of Brain Metastases in Thyroid Carcinoma

1997 • 252 citations

Influence of Diagnostic Radioiodines on the Uptake of Ablative Dose of Iodine-131

1994 • 219 citations

Thyroid Remnant ¹³¹I Ablation for Papillary and Follicular Thyroid Carcinoma

1997 • 215 citations

¹³¹I Therapy for Elevated Thyroglobulin Levels

1997 • 210 citations

Comparison of ¹⁸FDG-PET with ¹³¹Iodine and ^99mTc-Sestamibi Scintigraphy in Differentiated Thyroid Cancer

1997 • 150 citations

Prevalence of Fractures in Postmenopausal Women with Thyroid Disease

1993 • 148 citations

Resectional management of thyroid carcinoma invading the airway

1992 • 135 citations

Detection of Thyroid Remnant/Metastasis Without Stunning: An Ongoing Dilemma

1997 • 131 citations

Temporary Ovarian Failure in Thyroid Cancer Patients after Thyroid Remnant Ablation with Radioactive Iodine

1989 • 106 citations

Low Thyrotropin Levels Are Not Associated with Bone Loss in Older Women: A Prospective Study*

1997 • 92 citations

Dosimetric Considerations in the Radioiodine Treatment of Macrometastases and Micrometastases from Differentiated Thyroid Cancer

1997 • 83 citations

Medical Therapy for Differentiated Thyroid Carcinoma*

1994 • 79 citations

¹³¹I Treatment of ¹³¹I Negative Whole Body Scan, and Positive Thyroglobulin in Differentiated Thyroid Carcinoma: What Is Being Treated?

1997 • 72 citations

Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine¹³¹I and Recombinant Human Thyroid Stimulating Hormone

1997 • 70 citations

Stunned Thyroid after High-dose 1–131 Imaging

1992 • 55 citations

Percent ¹³¹I Uptake and Post-Therapy ¹³¹I Scans: Their Role in the Management of Thyroid Cancer

1997 • 47 citations

Recombinant Human Thyrotropin Is a Potent Stimulator of Thyroid Function in Normal Subjects

1997 • 45 citations

Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy

1996 • 40 citations

Is Serum Thyroglobulin a Useful Marker for Thyroid Cancer in Patients Who Have Not Had Ablation of Residual Thyroid Tissue?

1997 • 40 citations

Leukemia after a small dose of radioiodine for metastatic thyroid cancer.

1993 • 34 citations

Fractures After Thyroidectomy in Men: A Population-Based Cohort Study

1997 • 30 citations

Late Consequences of Radioiodine for Diagnosis and Therapy in Sweden

1997 • 29 citations

Conversion of Non-Iodine-Concentrating Differentiated Thyroid Carcinoma Metastases into Iodine-Concentrating Foci after Anticancer Chemotherapy

1997 • 29 citations

Metastasis to the Liver in Well-Differentiated Carcinoma of the Thyroid

1996 • 27 citations

Postoperative radioactive iodine evaluation of total thyroidectomy for thyroid carcinoma: Reappraisal and therapeutic implications

1992 • 20 citations

Regulations and Policies on Radioiodine ¹³¹I Therapy in Europe

1997 • 16 citations

Thyroid Ultrasonography—A Review

1997 • 16 citations

Treating Metastatic Thyroid Cancer

1993 • 13 citations